top biopharmaceuticals for glp-1 medication Shortages improve Lilly's weight loss drugs, bumping sales forecast by $3bn 2025 Pharma Trends: Keytruda, Mounjaro,

The results of the ATTAIN-MAINTAIN trial, published May 12 in Nature Medicine, showed that switching to the once-daily orforglipron pill may address this need and help maintain the cardiometabolic benefits

Keytruda's sales are expected to continue growing at least until 2027

Just a fast online intake and a licensed provider who ships your plan to your door

Governments plus healthcare organizations are putting money into healthcare infrastructure and chronic disease management programs

In 2021, the annual sales of the drug surpassed $10 billion for the first time, reaching $10.76 billion

What to Expect with Options Medical Weight Loss We tailor every program to meet your unique goals